̽����ѡ

Professor, Dept of Oncology-Pathology, ̽����ѡ, 2006-
Professor II, CCBIO, Bergen University, 2016-

Education
Associate Professor, Uppsala University, 1995
Post-doc, Cold Spring Harbor Laboratory, 1992-93
Ph.D., Uppsala University, 1990

Selected qualifications:

Author of more than 175 original research articles and 45+ reviews (Nat Rev Can (2), Cancer Cell, Trends in Cell Biology and Trends in Cancer); h-factor 70  (Web of Science).

Completed supervision of 14 PhD students and 22 post-doctoral fellows of which the majority continues academic research. Six of these are full professors and 9 have been promoted to PI or junior PI positions.

Coordinator STARGET – a Linnaeus center for translational studies on the tumor microenvironment with funding from VR 2006-16.

Co-director StratCan – the strategic research program in cancer at ̽����ѡ, 2010-18.

Member of the Nobel assembly (2020-) and the Nobel committee (2023, 2024 and 2025).

Ad-hoc reviewer for the Nobel Assembly and the Royal Academy of Science (Sjöberg Prize).

ERC Advanced Grant LS7 panel member (2023 and 2025).

Member of the Editorial Board Cancer Research (2015-).

Member of the board of “Svenska Sällskapet för Medicinsk Forskning” (2020-2025).

Supported by research grants from Swedish Cancer Society, Swedish Research Council, “Kreftforeningen”, Stockholm City Council (ALF), “Radiumhemmets forskningsfonder” and "HelseVest".

External grant reviewer for Cancerfonden, Barncancerfonden, SSMF, ERC and national European agencies including CRUK and Wellcome Trust. Reviewer for e.g. Nature, Nature Medicine, Nat Comm., Nat Rev Cancer, Nat Rev Clin Onc, Cancer Cell, EMBO J.

Main- or co-organizer of UICC Advanced Course of Cell Signaling and Cancer, 1999; Nobel Conference on Breast Cancer, 2012 and Swedish Cancer Research Meeting 2014.

Ad hoc member of international scientific advisory boards for e.g. ImClone, Eli-Lilly and Novartis.

Co-founder of TECKNET AB